(1) Introduction Epithelia function to protect the underlying tissues from environmental influences such as physical damage, bacterial infection, desiccation, ultraviolet irradiation, and heat loss and to maintain homeostasis. Epithelial tissues are classified, on the basis of their morphology and differentiationspecific expression patterns, into three broad classes: keratinizing (cornified) stratified squamous epithelia such as the epidermis, palate, and gingival tissue within the oral cavity; stratified non-keratinizing epithelia such as the buccal oral mucosa and the esophagus; and simple (non-stratified) epithelia such as the kidney and liver ( Fig. I ) (reviewed in Moll et al, 1982; Dale et al., 1990b; O'Guin et al., 1990) . A critical aspect of stratified, keratinizing epithelia is that the cells undergo a terminal differentiation program that results in the formation of a mechanically resistant and toughened surface composed of cornified cells (squames or corneocytes) that are filled with keratin filaments and lack nuclei and cytoplasmic organelles. In these squames, the cell membrane is replaced by a proteinaceous cornified envelope that is covalently cross-linked to the keratin filaments, providing a highly insoluble yet flexible structure that protects the underlying epithelial cells (Reichert et al., 1993; Steinert and Marekov, 1995; .
The epidermis is probably the best-studied example of a stratified keratinizing epithelium, largely as a result of the many diseases affecting skin, its ease of study, and the ability of epidermal keratinocytes to be cultured in vitro in defined serum conditions (for reviews, see Rheinwald, 1980;  Fuchs, 1990 ; Fuchs and Byrne, 1994) . A somewhat less-well-understood but equally important epithelial lining is that of the oral cavity, which shows a remarkable degree of regional variation with respect to morphology and keratinization (Meyer et al., 1984) . This review will focus on Figure 1 . The program of differentition in keratinizing and non-keratinizing epithelia of skin and oral mucosa.h Panels A and B show a schematic of the cell layers of keratinizing epithelia (epidermis, gingiva, hard palate) and o iseases a non-keratinizing buccal epithelium, respectively. The keratins expressed by each layer are indicated. Keratins K6 affect the skin and and Kl 6 are expressed by keratinizing oral mucosal epithelia but not in normal interfollicular epidermis (see text). oral epithelia, with The gingiva (panel C) is a complex oral tissue with both non-keratininized and keratinized regions. Keratin pro-particular emphatein expression in each region is indicated. Cells of the basal layer express K5 and K14 in al regions and also sis on disorders express KI 9 in the JE, SE, and AE. These cells are continuous with a layer of cells, having a similar expression that involve ker pattern, directly attached to the tooth. Each region has a unique suprabasal expression pattern (Salonen et a/., 1989; Dale et a/., 1 990b; Mackenzie et a/., 1991) . OGE, oral gingival epithelium; SE, sulcular epithelium; GM, atins or desmoso gingival margin; JE, junctional epithelium; AE, alveolar epithelium.
mal proteins, This review will not discuss proteins of the ferentiating cells of stratified epithelia, with the epidermis hemidesmosomal complex that function to link basal epitheand oral cavity as paradigms of epithelia that undergo keralial cells to the basement membrane. This topic has been the tinization or show regional variation in the degree and type of subject of several recent reviews (Green and lones, 1996;  (2) The Keratins (Steinert and Roop, 1988; Blumenberg, 1993; Fuchs and Weber, 1994 and/or interactions with other proteins and cell structures. The criical nature of the ca-helical rod, and in particular the extreme ends, in filament assembly has been elegantly demonstrated by transfection of mutant keratins into cultured cells and in vitro filament assembly studies with purified proteins (see below; reviewed in . Within stratified epithelia, the keratin pair K5/K 14 is expressed in the basal proliferative layer (Fig. I) . Keratin 19 also is expressed in basal cells of non-keratinizing epithelia, as well as in simple epithelia and some other specialized cell types such as bulge cells of hair follicles and Merkel cells (Moll et al., 1982; Michel et al-1995 , Su et al., 1996 . Differentiating suprabasal cells in the post-mitotic layers express a different keratin pair depending on the body site. Hence, epidermal and gingival tissue, examples of keratinized (cornified) epithelia, express keratins KI and KIO, while non-keratinized epithelia such as buccal mucosa, esophagus, and vagina synthesize predominantly K4 and K13 (Figs. la, lb; Table 1 ) (Dale et al., 1990b; O'Guin et al., 1990) . Suprabasal epithelial cells of the hard palate and gingiva also express K2, denoted K2p to distinguish it from epidermal K2e, which are the products of related but distinct genes (Collin et a)., 1992) . Some specialized epithelial cells within the gingiva exhibit a keratin expression pattern distinct from that of attached gingiva, thus, the sulcular epithelium and cells of the gingival margin express K4 and K13, while the junctional epithelium adjacent to the tooth surface produces K8, K 13, K 16, K 18, and K 1l9 (Dale et al., 1990b; Mackenzie et al.! 1991) . Keratins 8 and 18, markers of non-stratified epithelia such as the liver and kidney, are present as RNA transcripts in oral epithelia (Su et al., 1994) . The K8/K18 protein pair is not present in normal oral mucosal epithelia (apart from junctional tissue), while it is highly expressed in many types of oral cancers (Schaafsma et al., 1993; Su et al., 1994) . These proteins, however, are present in basal cells of the esophagus, a non-keratinized epithelium (Bosch et al., 1988) . Buccal mucosa tissue also expresses keratins KI and KIO in a sporadic fashion, with the mRNAs for these keratins being present in many more cells than the protein (Bloor et al. 1998 ). These authors suggested that the presence of KI nd KIO transcripts allows buccal epithelium to respond rapidly to a range of stimuli that put a heavier functional demand on the tissue, such as that seen in smokers or lichen planus patients (Bloor et al., 1998) . In summary, the regulation of keratin expression in oral epithelia is complex, and involves both transcriptional and post-transcriptional mechanisms that, together, control the pattern of protein expression.
In epidermis, K6 and K16 are not normally expressed, but are rapidly induced in suprabasal (postmitotic) cells during hyperproliferation of keratinocytes-for example, during wound healing or after treatment with retinoids or the tumor promoter TPA. Keratins K6/K16 also are present in epidermal disorders that involve hyperplasia (e.g., viral infections, psoriasis, cancer) and are expressed by cultured keratinocytes (reviewed in McGowan and Coulombe, 1998) . These studies have suggested that K6/K16 may have a special role in cytoskeletal maintenance during epidermal hyperproliferation. A recent study suggested that K16 can promote epithelial cell proliferation by down-regulating the function of phosphorylated retinoblastoma protein, which normally inhibits cell growth during keratinocyte differentiation (Paramio et al., 1999) . It is intriguing that, while K6 and K16 are not present in normal epidermis, they are constitutively expressed in some other stratified epithelia, including the tongue, palate, gingiva, nail, esophagus, hair follicle, and palm and sole epidermis (Moll et al., 1982; ., 1990b).
(B) SKIN DISORDERS ASSOCIATED WITH KERATIN MUTATIONS
A great many disorders that affect epidermal and mucous epithelia have been shown to result from mutations in keratin genes. These findings are summarized in several excellent recent reviews (Corden and McLean, 1996; Korge and Krieg, 1996; Bale and DiGiovanna, 1997) . These studies have also convincingly demonstrated the importance of these proteins in maintaining the mechanical integrity of epithelial tissues and, in particular, of epidermal keratinocytes. Mutations in keratin genes have been found to cause several dominantly inherited skin diseases, including epidermolysis bullosa (EB) simplex (involving mutations in K5 and K14), epidermolytic hyperkeratosis (mutations in KI and K10), ichthyosis bullosa of Siemens (K2e mutations), pachyonychia congenita (mutations in K6, K 16, and K 17), and epidermolytic palmoplantar keratoderma (EPPK) that results from mutations in K9, a keratin expressed in palm and sole epidermis (Table 1) . The vast majority of genetic alterations are point mutations that result in single amino acid substitutions in the a-helical rod domain of keratin proteins. The most severe forms, such as those which cause the EB type Dowling-Meara, result from mutations at the extreme ends of the rod domain, in conserved peptide sequences referred to as the helix initiation and termination peptides (Fig. 2) . These sequences are critical determinants of filament assembly and stability (Steinert, 1993; Fuchs and Weber, 1994) . Typical findings in the severe forms of EB and epidermolytic hyperkeratosis include redness and blistering upon mild trauma, hyperkeratosis (thickening of stratum corneum), disruption of the keratin cytoskeleton due to aborted filament assembly (usually seen as collapse into perinuclear bundles or aggregates), and cytolysis. The ker-atopathies affect different layers of the epidermis, primarily because the keratins are expressed in different cell layers (Fig. 1 Sybert, 1997) .
There are also several case reports involving mutations outside the OLhelical rod domain, which are typically less severe. One example is in a family with non-epidermolytic PPK that exhibits suprabasal cell fragility. The mutation is in the N-terminal head domain of keratin Kl (Kimonis et al., 1994) in a region that is known to bind to the desmosomal protein desmoplakin (Kouklis et al., 1994) . Other forms of non-epidermolytic PPK result from mutations in K16 (Shamsher et al., 1995) and in the desmosomal proteins desmoplakin (Keith et al., 1999) and desmoglein 1 (Rickman et al, 1999) (Tables 1, 2 ). Mutation within the non-helical head domain of K5 occurs in a rare form of EB with mottled pigmentation which displays defects in organelle distribution as well as keratin organization (Uttam et al., 1996; Irvine et al., 1997) . These two diseases highlight the importance of the interaction between keratin IFs and other cellular structures such as desmosomes (discussed below). Many of the cellular and gross phenotypic traits of these diseases can be reproduced by expression of truncated keratin genes that lack part of the (x-helical rod domain in transgenic mice, demonstrating the dominant-negative nature of these mutations in causing keratin IF disruption and cell fragility (reviewed in Fuchs, 1996) . This was first demonstrated for K14, one of the genes mutated in EB simplex (Vassar et al., 1991) . Mouse models for epidermolytic hyperkeratosis that express truncated KI and KIO proteins have also been reported Bickenbach et al., 1996) (Chan et al., 1994; Rugg et al., 1994; lonkman et al., 1996) (Jonkman et al., 1996; Waseem et al., 1999) and K14 "knock-out" mice (Lloyd et al., 1995) , keratin K15 was the "compensating" keratin partner and is up-regulated in basal cells of K14-ablated human epidermis and hair follicles. Clearly, however, although K15 (Richard et al., 1995; Rugg et al., 1995) (Table 1 ). In all cases published to date, the heterozygous mutations lie in the helix initiation peptide within the LA portion of the ox-helical rod domain. One of the mutations is a heterozygous three-base-pair deletion which removes a conserved asparagine from the helix initiation peptide of K4 .
Pachyonychia congenita is the name given to another group of autosomal-dominant epithelial disorders that exhibit various ectodermal abnormalities, including hypertrophic nail dystrophy and non-epidermolytic PPK (thickening of palms and soles). In the more common ladassohn-Lewandowsky form, there is also oral leukokeratosis (leukoplakia) very similar to that seen in white sponge nevus, while in the Jackson-Lawler type there is no oral leukokeratosis, but teeth that are often malformed are present at birth, and patients have cutaneous cysts (Feinstein et al., 1988) . Pachyonychia congenita involves mutations in the K6a and K16 genes (JadassohnLewandowsky type, PC-1) and K1 7 genes (Jackson-Lawler type, PC-2) ( Table 1) . In most cases, there is good correlation between the tissues affected in the two forms of PC and the expression pattern of the involved keratin genes. For example, the K6/K16 pair is expressed in nails, palm and sole skin, the hair follicle, and oral mucosa, which are all affected in the Jadassohn-Lewandowsky form. All mutations reported to date lie in the helix initiation LA peptide (Bowden et al., 1995; McLean et al., 1995; Smith et al., 1997) . In one family, affected individuals have a three-base-pair deletion within the helix initiation peptide of K6a which removes a highly conserved asparagine residue (Bowden et al., 1995) ; this K6 mutation is identical to the K4 mutation reported in two families with white sponge nevus . Other forms of non-epidermolytic PPK resulting from mutations in K16 and K17 have been reported that have only very mild nail abnormalities (Shamsher et al., 1995; Smith et al., 1997 (Ku et al., 1997) .
In summary, studies of keratin genes and associated epithelial disorders (keratinopathies) reveal several basic principles:
(1) Dominant disorders are associated with the expression of a protein whose function is altered by the mutation. The mutant protein, by some unknown mechanism, disrupts the stability and function of preformed keratin filaments.
(2) Disorders affecting keratins K5 and K14 can have widespread epithelial effects, because this keratin pair is expressed in the basal layer of most stratified epithelia.
(3) Region-specific disorders (e.g., epidermolytic hyperkeratosis, white sponge nevus; Table 1 ) result from mutations in differentially expressed keratins.
(4) Common sites are altered in different keratin proteins (e.g., residues in the IA helix initiation and 2B termination peptides), suggesting the critical importance of these regions in keratin filament assembly and function.
(3) Profilaggrin/Filaggrin Filaggrin is an abundant protein expressed in differentiating keratinocytes that functions to aggregate keratin IFs into tightly aligned bundles or macrofibrils in the stratum corneum of the epidermis and other stratified keratinizing epithelia, including the gingiva and tongue (Dale et al., 1978; Manabe et al., 1991; reviewed in Dale et al., 1990b reviewed in Dale et al., , 1993 . It is synthesized in suprabasal granular cells, as a large, highly phosphorylated precursor, profilaggrin, that consists of multiple filaggrin repeats flanked by N-and C-terminal domains that differ from filaggrin. In humans, profilaggrin contains between 10 and 12 filaggrin units (Gan et al., 1990 ). Profilaggrin is a major component of keratohyalin granules, a nonmembrane-bound cytoplasmic organelle that is readily visible by histology. Profilaggrin is phosphorylated by at least two kinases in granular cells: casein kinase II and PKC6 (Old, Ahn, and Resing, unpublished observations). The latter enzyme appears to play a role in processing by acting to make profilaggrin more soluble. During terminal differentiation, profilaggrin is modified by additional enzymes that dephosphorylate and proteolytically cleave it to yield filaggrin, which functions in the lower stratum corneum to aggregate keratin IFs (reviewed in Dale et al., , 1994 . Enzymes thought to be involved in profilaggrin processing include protein phosphatase PP2A , and the endoproteinases profilaggrin endo-proteinase 1, a chymotrypsin-like protease (Resing et al, 1995) , calpain Yamazaki et al., 1997) , and furin (Dale et al, 1997a) . The association of filaggrin with keratins is believed to facilitate disulphide bond formation between keratin polypeptide chains, and may enable them to survive the massive remodeling that ensues with terminal differentiation. Subsequently, filaggrin is degraded to free amino acids which function to bind water and are be- lieved to play an important role in maintaining the osmolarity and flexibility of epidermis (see below). A small amount of filaggrin escapes complete degradation and becomes incorporated into cornified envelopes (Steinert and Marekov, 1995, Simon et al., 1996) .
Recent studies have shown that filaggrin has dramatic effects on the IF cytoskeleton when expressed in epithelial cells, supporting the notion that filaggrin is a keratin IF-binding protein in vivo. Overexpression of filaggrin in epidermal keratinocytes and simple epithelial cells resulted in the collapse of both keratin and vimentin filament networks into perinuclear coils and aggregates (Dale et al., 1997b; Kuechle et al., 1999) . Filaggrin has many other effects on cells, including alteration of cell shape (to a more rounded morphology), condensation of cell cytoplasm, and arrest of cells prior to mitosis; cells expressing filaggrin also displayed decreased cell-cell adhesion that was associated with altered distribution of desmosomal components, in particular the keratinbinding protein desmoplakin (Presland, Kuechle, Lewis, Fleckman, and Dale, unpublished observations) . In addition, filaggrin-expressing lines appear to be more susceptible to apoptosis induced by agents such as ultraviolet light (Kuechle et al, 2000) . These findings suggest that the integrity of the keratin filament network is necessary for desmosome stability. Other studies, including transgenic mice that overexpress keratin 16 and exhibit aberrant distribution of keratin IFs and desmosomal proteins, support this notion (Paladini and Coulombe, 1998) .
The distinct N-terminal domain of profilaggrin contains two calcium-binding motifs, termed EF-hands, which are able to bind calcium in vitro (Presland et al, 1992 Markova et al, 1993) . Both the Ca2+-binding (A) domain and, to a lesser extent, the downstream cationic B domain are conserved between species, suggesting a functional role(s) for this peptide. Profilaggrin is one of a number of S-100 calcium-binding proteins that are expressed in keratinizing epithelia including epidermis; others include trichohyalin, SIOOAIO, and SIOOAI I (see below). It has been proposed that the Ca2l-binding domain functions as a calcium reservoir in granular cells, allowing profilaggrin to regulate its own calcium-dependent processing to filaggrin (Presland et al., 1997) . Recent studies also suggest that the N-terminal domain of profilaggrin may play a role in rendering profilaggrin insoluble and hence may be important for keratohyalin formation.
The N-terminal Ca2l-binding domain undergoes specific proteolytic cleavage during keratinocyte terminal differentiation and is thought to be an early step in profilaggrin processing (Presland et al., 1997) A candidate protease for this N-terminal cleavage is furin, a member of the proprotein convertases of calcium-dependent endoproteases that are involved in the maturation of many hormones and growth factors (reviewed in Nakayama, 1997) . Evidence for involvement of this enzyme in profilaggrin processing includes, the presence of at least one furin cleavage site in the profilaggrin N-terminus, in vitro cleavage of a recombinant profilaggrin peptide by furin enzyme, and expression of furin in granular cells of human epidermis (Dale et al., 1997a) .
A distinct function of the N-terminal profilaggrin peptide is suggested by its localization in the nucleus of terminal differentiating (transition) cells and the persistence of this peptide in parakeratotic nuclei of certain human skin diseases, including loricrin keratoderma (a disease involving mutations in the CE protein loricrin) and the hyperproliferative disorder psoriasis (Fig. 3) . Ishida-Yamamoto et al. suggested that this peptide may play a role in the nuclear breakdown or other nuclear events that occur during terminal differentiation.
In the upper stratum corneum, filaggrin is degraded mostly into free amino acids, which function to provide the constituent amino acids thought to be important for the maintenance of epidermal osmolarity and flexibility (Scott et al., 1982; Rawlings et al., 1994) . Some of these filaggrin-derived amino acids are chemically or enzymatically modified, such as the compound pyrrolidone carboxylic acid, which is derived from glutamine and is abundant in cornified cells of epidermis (Wolfersberger et al., 1973; Thulin and Walsh, 1995) . These modified amino acids, and in particular pyrrolidone carboxylic acid, are highly hydroscopic compounds that can absorb a large amount of water even at relatively low humidities. Another modified amino acid, citrulline, is produced from arginine by the enzyme peptidyl arginine deiminase (Tarcsa et al., 1996) . The cornified cells are thought to control the formation of these amino acids by regulating the activity of the filaggrin-degrading protease in relation to the relative humidity (Scott and Harding, 1986) .
The functional importance of these filaggrinderived amino acids has long been disputed (see Rawlings et al., 1994) . Perhaps the best evidence that these amino acids do play a role in normal epidermal flexibility and desquamation is the human skin disorder ichthyosis vulgaris (IV). This disorder is characterized phenotypically by dry, flaky skin and biochemically by reduced or absent profilaggrin expression (Sybert et al., 1985; Nirunsuksiri et al., 1995 Nirunsuksiri et al., , 1998 . The defect in IV appears to be specific to profilaggrin, since other markers of epidermal differentiation such as keratin 1 or loricrin are expressed normally (Nirunsuksiri et al., 1995) . The dry, scaly skin in IV can be explained by the absence of the filaggrin-derived amino acids that normally maintain the cornified cells in a hydrated state. The spontaneous mouse mutant, flaky tail (ft) (Lane, 1972; Sundberg, 1994) , exhibits many of the features of human IV, including a dry, scaly skin, and attenuated profilaggrin/filaggrin protein with normal expression of other differentiation markers (Presland et al., 2000) . Hence, this mouse mutant appears to be a good model for human IV and should provide insight into the relationship between profilaggrin/filaggrin deficiency and dry, scaly skin.
Other disorders in which there are alterations in profilaggrin/filaggrin expression include Harlequin ichthyosis (Dale et al., 1990a; and epidermolytic hyperkeratosis (Ishida-Yamamoto et al., 1994) . In some types of Harlequin ichthyosis, a severe skin disease of unknown etiology, profilaggrin is expressed but not processed to filaggrin, while in epidermolytic hyperkeratosis, a disease involving mutations in keratins Ki and K10, filaggrin is often overexpressed and may contribute to the filament clumping in this disease. The sera of some patients with the autoimmune disease rheumatoid arthritis react with a neutral/acidic form of filaggrin (Simon et al., 1993; Slack et al., 1998; Girbal-Neuhauser et al., 1999) . These antibodies were originally termed "anti-keratin antibodies" because of their strong reaction with rat esophageal epithelium and human epidermis. While further work still needs to be done, it is likely that the autoantigen is a citrulline-modified protein present in rheumatoid cartilage (pannus) tissue that happens to cross-react with citrulline-modified (deiminated) filaggrin present in epidermis (Girbal-Neuhauser et al., 1999) .
(4) Trichohyalin
Trichohyalin is a protein that was originally characterized from sheep and guinea pig hair follicles, where it is a major component of the inner root sheath and medulla cells (Rothnagel and Rogers, 1986) . It is also expressed in the keratinizing filiform papillae of the tongue, the nail matrix, the epithelial cells lining the sheep rumen, and in newborn foreskin epidermis as well as in isolated cells of normal adult epidermis (Hamilton et al., 1991; Fietz et al., 1993; Manabe and O'Guin, 1994) . In inner root sheath cells of hair follicles, trichohyalin, like profilaggrin, initially accumulates in cytoplasmic electron-dense granules. Later, as these cells terminally differentiate, the antibody labeling is found throughout the IF network of inner root sheath cells of follicles, suggesting that trichohyalin functions as a matrix or keratin IFassociated protein (Rothnagel and Rogers, 1986) . A similar conclusion was reached by O'Guin and colleagues, who used a panel of monoclonal antibodies to human trichohyalin in a detailed electron microscopy study (O'Guin et al., 1992) . One of the antibodies, AE17, bound the IF bundles in inner root sheath cells with a 400-nm periodicity, suggesting that trichohyalin recognizes a binding site on keratin IF.
The complete amino acid sequences of sheep, rabbit, and human trichohyalin have been determined from the sequencing of cDNA and genomic clones (Rogers et al., 1991; Fietz et al., 1993; Lee et al., 1993 (Manabe and O'Guin, 1994; . It is highly expressed in stratified epithelia subject to severe mechanical stress such as the mouse forestomach, sheep rumen, and filiform ridges of the tongue (Rogers et al., 1997) . In fact, trichohyalin and another CE component, the small proline-rich proteins (SPRs) (discussed below), are proposed to function as cross-bridging proteins between other CE components, providing enhanced mechanical strength to epithelial tissues such as the rodent forestomach (Table 3) (Steinert et al., 1998b) . Both the SPRs and trichohyalin contain high levels of lysine and glutamine, allowing for efficient incorporation into the CE by transglutaminases (Tarcsa et al., 1997 Green and Jones, 1996) . present in stratified and simple epithelia and in certain other specialized tissues, such as the myocardium and follicular dendritic cells of the lymph system. Desmosomal proteins include the integral (membranespanning) proteins, the desmogleins and desmocollins, which are members of the cadherin superfamily; the cytoplasmic plaque proteins desmoplakin and plakoglobin that function to link IFs to the desmosomal cadherins; and several plaque-associated proteins such as plakophilin, envoplakin, and periplakin ( Fig. 4 ; Table 2) (reviewed in Green and Jones, 1996; Kowalczyk et al., 1999a) . Assembly of desmosomes in cultured epithelial cells is regulated by calcium, with assembly occurring rapidly when cultured cells are switched into a high-calcium medium. This assembly process involves specific phosphorylation or dephosphorylation of desmosomal proteins and probably regulation of desmosomal cadherin function by calcium. Several genetic and autoimmune diseases involving desmosomal proteins have been described, highlighting the importance of this structure in epithelial cell-cell adhesion and tissue function. (Stanley, 1993; Kowalczyk et al., 1999a) . By analogy with classic cadherins, desmosomal cadherins are thought to mediate cell adhesion through calcium-mediated homophilic and/or heterophilic interactions between their extracellular domains (shown schematically in Fig. 4 ). Desmogleins and desmocollins are generally expressed as pairs in a tissue-specific fashion; for example, in human epidermis, desmoglein 1 is expressed in suprabasal cell layers, desmoglein 2 in the basal layer only, while desmoglein 3 is in the basal and immediate suprabasal layers along with one or more members of the desmocollin family (Kowalczyk et al., 1999a) . Desmoglein 3 is the predominant desmoglein in both keratinizing and non-keratinizing oral mucosa, with lower levels of desmoglein 1 also detectable (Shirakata et al., 1998) .
The evidence that the desmosomal cadherins, and in particular desmoglein, are important for desmosome stability and the mechanical integrity of stratified epithelia is largely derived from studies of two diseases, pemphigus vulgaris (PV) and pemphigus foliaceus. The pemphigus diseases are autoimmune blistering disorders in which separation of the suprabasal layers is found in conjunction with circulating desmoglein autoantibodies which label the cell surfaces of keratinocytes by direct immunofluorescence (reviewed in Amagai, 1996; Dabelsteen, 1998) . The pemphigus diseases are frequently life-threatening, but now can be treated with corticosteroids. Both forms of pemphigus affect the epidermis, while PV also involves erosions of other mucosa, especially the oral cavity. Investigators have shown the autoantigen in PV to be desmoglein 3 by screening a keratinocyte cDNA expression library with purified autoantibody (Amagai et al., 1991) , although many patients with PV also have circulating antibodies to desmoglein 1 (Amagai et al., 1999) . A different member of the desmoglein family, desmoglein 1, is the predominant autoantigen in pemphigus foliaceus (reviewed in Amagai, 1996) . These desmoglein autoantibodies cause blistering when injected into neonatal mice, providing direct evidence that these antibodies are involved in the pathology of these diseases. While PV affects both mucosal and cutaneous tissues, oral involvement is rarely seen in pemphigus foliaceus, probably because of the low expression of desmoglein 1 in mucosal epithelia (Shirakata et al., 1998) .
The importance of desmoglein 3 in epithelial cell-cell adhesion and tissue integrity was elegantly demonstrat-ed by targeted gene disruption in mice (Koch et al., 1997) . Oral lesions resulting from a split above the basal layer are a prominent finding in the desmoglein-3-deficient mice. The mice were runted, documenting their impaired ability to process solid food, which is also a common problem in human PV patients. Epithelial tissues were often inflamed and displayed a "row of tombstones" morphology of basal cells that have separated from each other and the immediate suprabasal cell layers. In the genetically deficient mice, other epithelia affected included the epidermis in areas prone to trauma, eyelids, and conjunctiva, regions which also are affected in some patients (Koch et al., 1997) . One feature that was unique to the mice was a hair loss phenotype, which implicated desmoglein 3 in the normal adhesion of cells in the hair follicle. Subsequently, a spontaneous mouse mutation, balding (bal), that shows a similar hair loss phenotype was shown to contain a mutation in desmoglein 3. The bal mice lack desmoglein 3 protein and show many features in common with the genetically deficient mice, including oral blisters (Koch et al, 1997; Montagutelli et al., 1997) . A mutation of human desmoglein I that removes part of the extracellular domain was recently reported in a family with an autosomal-dominant form of striate PPK (Rickman et al., 1999 . Both biochemical studies and sequence-based structure predictions suggest that the (x-helical rod domain of desmoplakin mediates homodimer formation, and possibly the formation of higher-order structures within desmosomal plaque (reviewed in Kowalczyk et al., 1999a) .
The plakin family of proteins shares a common structure of an cx-helical rod domain and a C-terminal domain that contains a variable number of related tandem repeats which functions to bind IF proteins . Binding of keratin IFs has been clearly demonstrated for desmoplakin and plectin by transfection of cDNA expression constructs into cultured cells. For example, over-expression of constructs encoding the desmoplakin C-terminal domain caused the protein to coalign with, and eventually collapse, the keratin and vimentin IF cytoskeletons (Stappenbeck and Green, 1992; Stappenbeck et al., 1993) . Similar results have been obtained in transfection experiments with plectin, the hemidesmosome protein that interacts with keratins of basal cells (Wiche et al., 1993) . The C-terminal domain of DPI has also been shown to bind type 11 keratins (including KI and K5), by the use of both yeast two-hybrid assays (Meng et al., 1997) and by direct in vitro binding assays with purified proteins (Kouklis et al., 1994) . The interaction of desmoplakin with IFs is abrogated by phosphorylation of the C-terminal domain of desmoplakin and may regulate keratin IF-desmoplakin interactions during desmosome assembly (Stappenbeck et al., 1994) . The N-terminal domain of desmoplakin is required for targeting the protein to desmosomes, where it associates with several proteins, including plakoglobin (y-catenin) and desmocollin ( Fig. 4) (Stappenbeck et al., 1993; Bornslaeger et al., 1996; Kowalczyk et al., 1997; Smith and Fuchs, 1998) .
Desmoplakin, and by extension desmosomes, plays an essential role in embryonic development. This is most dramatically apparent in desmoplakin-deficient mice, which do not survive beyond embryonic day 6.5, due to a failure of desmosomes to form normally in post-implantation embryos (particularly in endodermal tissue) and loss of keratin IF attachment in those cells (Gallicano et al., 1998) . Adherens junctions that were E-cadherin-positive appeared to form normally, showing that the loss of cell adhesion is related to the loss of desmosomes rather than other types of adherence junctions. A mutation in human desmoplakin was recently reported in a large family with an autosomaldominant form of striate PPK, a skin disease that affects fingers, palms, and soles (Keith et al., 1999 (Simon and Green, 1984) . They now are recognized to be members of the plakin family that share a structure simi-lar to that of desmoplakin, although they contain shorter C-terminal domains (Ruhrberg et al., 1996a Aho et al., 1998 . In vitro studies suggest that these proteins can interact to form heterodimers, although they are not always co-expressed in vivo.
Several plakin family members (desmoplakin, envoplakin, periplakin), indeed many desmosomal proteins, have been detected in purified cornified envelope preparations (Table 3 ). This led to the proposal that the desmosome may provide the backbone for the initial stages of cornified envelope assembly, when involucrin and other proteins are added (Steinert and Marekov, 1997 ; see section below).
Paraneoplastic pemphigus (PNP) is a newly characterized autoimmune blistering disease associated with several forms of cancer, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia (Anhalt, 1997) . Patients exhibit severe blisters and ulcerations in the oral cavity and blistering skin eruptions. Autoantibodies to several desmosome proteins are present in sera of affected individuals, including desmogleins 1 and 3 (the autoantigens in two other forms of pemphigus, discussed above), desmoplakin, periplakin, and envoplakin (Kim et al., 1997; Amagai et al., 1998; Kiyokawa et al., 1998; Mahoney et al., 1998; Borradori et al., 1998) . In addition, PNP sera contain antibodies to another plakin family member, the hemidesmosome protein BP 230 (BPAG1), and an unidentified protein of 170 kDa. Mahoney et al. (1998) showed that one of the dominant epitopes in PNP sera was a conserved C-terminal peptide of plakin family proteins, while autoantibodies to desmoglein 3, affinitypurified from PNP sera, were able to induce blister formation in neonatal mice . In addition to PNP, envoplakin is a candidate gene in tylosis, an autosomal-dominant form of non-epidermolytic PPK that is associated with an increased risk of esophageal cancer (Kelsell et al., 1996; Ruhrberg et al., 1996b) . Plakoglobin is the only protein normally found in both desmosomes and adherens junctions. It is a member of the Armadillo gene family that also includes 1-catenin, a widely expressed protein that functions both as a structural component of adherens junctions and as a signaling molecule in the Wingless/\nt pathway (Ben-Ze'ev and Geiger, 1998). In desmosomes, plakoglobin interacts with desmosomal cadherins (desmogleins and desmocollins) and with the N-terminus of desmoplakin (reviewed in Green and Jones, 1996; Kowalczyk et al., 1999a) . Thus, it links desmosomal plaque proteins (e.g., desmoplakin) with those proteins that traverse the membrane and function in the extracellular environment (Fig.  4) (Karnovsky and Klymkowsky, 1995; reviewed in Ben-Ze'ev and Geiger, 1998) . However, more recent studies do not support a signaling role for plakoglobin, but did suggest a role in cell-cell adhesion (Kofron et al., 1997) . A role in cell adhesion is supported by knock-out experiments; thus, mice that lack plakoglobin frequently die midway through embryonic development, due to rupture of cardiac ventricles, probably as a result of poorly functioning desmosomes in the myocardium (Bierkamp et al., 1996; Ruiz et al., 1996) . Mice that survive until late gestation exhibit a skin blistering phenotype with acantholysis (loss of adhesion) in the differentiating layers. Interestingly, j-catenin is present in desmosomes of keratinocytes from plakoglobin-null mice, suggesting that 1-catenin can at least partially substitute for the loss of plakoglobin (Bierkamp et al., 1999) . Plakoglobin is one of several desmosome proteins that undergo tyrosine phosphorylation, which appears to regulate desmosome assembly positively during keratinocyte differentiation (Calautti et al., 1998) .
The plakophilins are a family of three desmosomal proteins that also are members of the Armadillo repeat family. They are not obligate desmosomal components and thus have not been considered essential for IF anchorage. For example, the best-known member, plakophilin 1 (band 6), is restricted to stratified and complex epithelia (Kapprell et at., 1988; Hatzfeld et al., 1994) . However, the demonstration of an ectodermal dysplasia that involves a mutation in plakophilin 1 and results in complete loss of expression shows that this protein has a significant function in at least some stratified epithelia. The pathologic lesions were restricted to skin, hair, and nails, with acantholysis (loss of cell-cell adhesion) of epidermal cells and altered keratin IFdesmosome connections (McGrath et al., 1997) . Keratin filaments were collapsed into perinuclear aggregates in lesional skin, reminiscent of some of the keratin disorders. Plakophilin 1 binds desmoplakin, desmocollin, and some epidermal keratins in vitro, supporting an accessory role for plakophilin in connecting keratins to desmoplakin and other desmosomal proteins (Fig. 4) (Smith and Fuchs, 1998; Kowalczyk et al., 1999b) . In the patient with the plakophilin mutation, desmoplakin distribution also appeared to be perturbed in epidermal cells (McGrath et al., 1997) , confirming the association between plakophilin 1 and desmoplakin observed in vitro.
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Other desmosomal plaque proteins include plectin, the plectin-related protein IFAP-300, a calmodulin-binding protein termed desmocalmin or keratocalmin, pinin, and desmoyokin (reviewed in Kowalczyk et al., 1999a) . Plectin is a member of the plakin family that is best known as a hemidesmosome component which associates with several IF proteins, including keratins in basal cells (Foisner et al., 1988; Wiche et al., 1993) . Mutations in plectin result in a recessive form of EB that is associated with skin fragility and late-onset muscular dystrophy (reviewed in Uitto et al., 1996) .
While much is now known about desmosomal proteins and how they interact to form functional desmosomes, the regulation of desmosome assembly is much less clear (see also section 7). Recent work in which desmoglein I and chimeric E-cadherin-desmoglein 1 molecules were overexpressed in epithelial cells suggests that normal desmosome assembly requires the formation of adherens junctions or at least the presence of a functional E-cadherin-plakoglobin complex at the cell surface (Norvell and Green, 1998) . Adherens junctions are composed of classic cadherins (E-and P-cadherin in epithelial cells) that interact with actin microfilaments via linker molecules including plakoglobin, 3-catenin, atcatenin, and cx-actinin. Taken together with the findings that E-cadherin can localize to desmosomes (Wheelock and lensen, 1992 ; Lewis et al., 1994 Lewis et al., , 1997 , and that an Ecadherin-plakoglobin complex may recruit desmoplakin to desmosomes, analysis of the data suggests that E-cadherin (perhaps complexed with other adherens junction components) either plays a direct structural role or provides an intracellular signal necessary for desmosome assembly (Norvell and Green, 1998i. (6) Proteins of the Cornified Cell Envelope
The cornified envelope (CE) is a 15-nm-thick cross-linked sheath of protein that is deposited on the inner face of the plasma membrane of keratinocytes during terminal differentiation. It is a vital part of the toughened cell surface and barrier function of stratified keratinizing epithelia, including the epidermis, keratinizing oral mucosa, and rodent forestomach. Some of the CE components, such as involucrin, and transglutaminase, an enzyme essential for CE formation, are expressed in non-cornified epithelia, although these tissues do not make conventional CEs. All of the CE components are expressed in suprabasal cells of keratinizing epithelia (often in precursor or inactive forms); the proteins are subsequently incorporated into the CE during t-he process of keratinization as cells undergo the transition from granular to cornified cell layers (Fig. I ) (reviewed in Reichert et al., 1993; . In the last few years. development of sophisticated chemical methods for the isolation of CE proteins and peptide microsequencing has led to the identification of a large number of proteins that are major or minor components of the CE (Table 3 ). The most abundant CE proteins (e.g., loricrin, SPRs, involucrin) are rich in lysine and glutamine and function primarily as CE components; others (e.g., keratins, filaggrin, desmoplakin, envoplakin) are keratin, keratin-associated, or desmosomal proteins; while other proteins (e.g., S-100 proteins, annexins, elafin) have functions in growth and differentiation as well as being minor, perhaps even accidental, CE components. To date, there are two skin diseases associated with CE formation and function: lamellar ichthyosis, a recessive disorder involving mutations in the enzyme transglutaminase 1, and loricrin keratoderma, a dominant disease resulting from mutations in loricrin.
(A) LORICRIN Loricrin is a protein rich in glycine, serine, and cysteine that is expressed in granular cells of epidermis and other keratinized epithelia, including the gingiva, hard palate, and rodent forestomach (Hohl et al., 1991; Hohl and Roop, 1993) . It functions as the major CE component, constituting 65-85% of total cross-linked protein of human and mouse foreskin epidermis Steven and Steinert, 1994; Steinert and Marekov, 19951 . Sequence predictions suggest that loricrin forms a flexible structure that consists of glycine-rich loop motifs separated by glutamine-rich linker sequences (Hohl et al., 1991) which allow for the formation of both interchain and intrachain cross-links catalyzed by transglutaminases 1 and 3, respectively (Candi et al, 1995) . Loricrin varies in size both within and between species (26 kDa in humans; 38 kDa in mouse) as a result of variable numbers of glycine loop motifs in the central portion of the protein (Mehrel et al., 1990; Hohl et al., 1991) .
In mouse epidermis, loricrin is initially expressed in granular cells and forms keratohyalin granules termed Lgranules that are morphologically distinct from profilaggrin-containing F-keratohyalin (Steven et al., 1990; Manabe et al., 1991; Dale et al., 1994) . In human epithelia, loricrin does not localize to L-granules except in newborn foreskin epidermis and acrosyringium (the epidermis surrounding sweat ducts) (Ishida-Yamamoto et al., 1993 . In intact human epidermis, loricrin is cross-linked to a large number of other CE proteins, including the SPR (small proline-rich) proteins I and 2, KI, K2e, K1O, filaggrin, and elafin/SKALP (Steinert and Marekov, 1995 Eckert et al., 1993; Simon, 1994) . Only recently, however, was involucrin unequivocally shown to be a CE component in vivo (Steinert and Marekov, 1995, 1997) . Like loricrin and SPRs, it consists of short peptide repeats that are rich in glycine, lysine, and glutamine and that vary in number and amino acid sequence within the mammalian lineage (Green and Djian, 1992) . It is now clear that involucrin is a major component of the inner, or scaffold, layers of the CE, along with other proteins, including cystatin ax (a proteinase inhibitor), desmoplakin, elafin, keratins, and SPRs (Table  3) . Involucrin, in addition to acting as a scaffolding protein for assembly of both "early" and "late" CE components, also acts as a scaffold to which lipids (predominantly ceramides, but also cholesterol esters and free fatty acids) are covalently attached. Other proteins with ceramides attached by ester linkages include envoplakin and periplakin (Marekov and Steinert, 1998) . Ceramides are synthesized in epidermal spinous cells as acylglucosylceramides and are further processed in granular cells, where they localize to a distinct membrane-bound structure, the lamellar granule (Wertz and Downing, 1983a,b; Madison et al., 1987) . During terminal differentiation, the lipids are extruded from lamellar granules into the intercellular space between cornified cells, where they contribute to the barrier function of skin, helping to prevent desiccation (reviewed in Elias et at., 1998a).
(C) SMALL PROLINE-RICH PROTEINS (SPRs)
The small proline-rich proteins (SPRs) consist of three subfamilies (SPRI, 2, and 3) of 14 related proteins that were first identified as UV-and phorbol-ester-inducible genes by differential screening of a human epidermal keratinocyte cDNA library (Kartasova and van de Putte, 1988; Gibbs et al., 1993) . SPRs have been identified in many mammalian species, including the rabbit (originally called cornifins; Marvin et al., 1992) and the mouse Song et al., 1999) . Other members of the SPR family were independently characterized from cultured human keratinocytes (Greco et at., 1995) . They are rich in proline (up to 40%) and contain a central domain that consists of peptide repeats of either 8 or 9 amino acids. The N-and C-terminal domains contain the lysine and glutamine residues that participate in transglutaminase-catalyzed cross-links (Robinson et al., 1997; Steinert et al., 1998a) . SPRs show widespread expression in stratified keratinizing external and internal epithelia; for example, SPR I is present in the forestomach, footpad, vagina, hair follicle, esophagus, lips, and tongue (Hohl et al., 1995; Jarnik et al., 1996; Kartasova et al., 1996) . The SPR3 protein is most abundantly expressed in the oral epithelia, esophagus, and mouse forestomach (Hohl et at., 1995; Austin et al., 1996) . In the mouse, SPR2 proteins are encoded by 11 closely related genes that display overlapping, but not identical, patterns of expression (Song et al., 1999 (Steinert et al., 1998b) . Other internal wet epithelia in which these proteins are abundantly expressed include the sheep rumen, tongue, vagina, uterus, and esophagus (Fietz et al., 1993; O'Keefe et al., 1993; Kartasova et al., 1996; Song et al., 1999) . At least in the mouse forestomach, the SPRs act as cross-bridging (intermediary) proteins that link other CE components, such as loricrin, involucrin, and trichohyalin (Steinert and Marekov, 1995; Steinert et al., 1998a,b) .
(D) OTHER CE COMPONENTS
A great many other proteins have been identified as components of CEs of newborn epidermis (see Table 3 ). (Zettergren et al., 1984; Takahashi et al., 1994) . Cystatin ox is identical to the previously identified transglutaminase substrate termed keratolinin (Takahashi et al., 1997) . Elafin/SKALP, an inhibitor of elastase and proteinase 3, is expressed in fetal epidermis but is down-regulated shortly after birth; however, it is expressed in other stratified epithelia of adults, including the tongue, gingiva, esophagus, and vagina, as well as in certain epidermal diseases, including psoriasis (Pfundt et al., 1996) . SIOOAll, and SIOOA1O (Steinert and Marekov, 1995; Robinson et al., 1997; Steinert et al., 1998a,b) (Table  3) . Robinson et al. (1997) proposed that annexins and S-100 proteins function as "envelope organizer proteins", transporting early CE components to the site of envelope 396
Crit Rev Oral Biol Med assembly at the plasma membrane in a calcium-dependent manner. This is an interesting hypothesis relevant to the subsequent role of transglutaminases, which are calcium-dependent enzymes. Last, it should be noted that the composition of CE can vary quite widely Steven and Steinert, 1994) . Until recently, CE composition was thought to be a result of what substrates are available for transglutaminase-mediated cross-linking in differentiating cells, a notion popularly referred to as the "dustbin" or "trash can" hypothesis (Michel et al., 1987) . While this may be a partially valid model, it is now clear that CE assembly is an orderly process that initially involves attachment and cross-linking of "early" components, including involucrin, cystatin a, and desmosomal proteins (e.g., desmoplakin, envoplakin) that are covalently attached to lipids. Subsequently, other proteins are added to the envelope by transglutaminase, including SPRs, loricrin, keratins, trichohyalin, and filaggrin, yielding "mature" CEs. The whole structure is stabilized by covalent attachment to the internal keratin cytoskeleton and to extracellular lipids (larnik et al., 1998; Steinert et al., 1998b) . Some of the minor CE proteins (e.g., annexins, S100 proteins, plasminogen activator inhibitor 2) have been detected only in vitro; indeed, cultured keratinocytes probably serve as a good model for the early stages of CE assembly (Steven and Steinert, 1994; Robinson et al., 1997) .
(E) DISEASES ASSOCIATED WITH CE ASSEMBLY AND FUNCTION
Cornified envelope formation involves the formation of two covalent linkages: E-('y-glutamyl) lysine bonds, formed by the action of calcium-dependent transglutaminase enzymes (principally transglutaminases 1 and 3); and disulfide bonds catalyzed by sulfhydryl oxidase (Yamada et al., 1987) . The importance of transglutaminases in CE formation is dramatically illustrated by lamellar ichthyosis, a severe skin disease that results from loss of function mutations in transglutaminase 1. Mutations include point mutations, deletions, and truncations that affect enzyme function, protein stability, and/or normal proteolytic processing of the transglutaminase 1 precursor protein to the active enzyme (Huber et al., 1995a; Russell et al., 1995; Candi et al., 1998) . The importance of this enzyme was confirmed by the recent targeted disruption of the transglutaminase I gene in mice, which results in a severely compromised cornified envelope with loss of a functional skin barrier and death shortly after birth (Matsuki et al., 1998) . While transglutaminase 1 appears to be a critical enzyme in the cross-linking process, transglutaminase So far, the only disorder to be caused by a defect in a CE structural protein is loricrin keratoderma (Christiano, 1997) . This is a rare skin disease characterized by palmoplantar hyperkeratosis (thickening of the cornified layers of palms and soles) with retention of nuclei, and constricting bands encircling the digits of the hands and feet (Maestrini et al., 1996; Korge et al., 1997; . The disease results from mutations in loricrin that lead to a frame shift and C-terminal extension of the encoded protein. The mutant loricrin is poorly incorporated into CEs and is retained in parakeratotic nuclei present in cornified layers. The nuclear localization of loricrin was suggested to be a direct result of the mutation, which creates basic motifs at the C-terminus reminiscent of nuclear targeting sequences (Maestrini et al., 1996; Korge et al., 1997) . However, profilaggrin is also retained in nuclei of the patient's epidermis, suggesting that there is a more general disruption of the normal terminal differentiation and desquamation process (IshidaYamamoto et al., 1998) . Incomplete differentiation with retention of both profilaggrin and loricrin-containing keratohyalin granules was also seen in transglutaminase-ldeficient mice, revealing an intricate interplay between terminal differentiation and CE assembly (Matsuki et al., 1998) . The mutilating keratoderma characteristic of loricrin keratoderma is also exhibited in another skin disease, Vohwinkel's syndrome, which results from a missense mutation in the gap junction protein connexin 26 (Maestrini et al., 1999) . Patients with Vohwinkel's syndrome exhibit sensori-neural deafness and lack the icthyosis characteristic of loricrin keratoderma (Korge et al., 1997; Maestrini et al., 1999 (Yuspa et al., 1989; Leigh and Watt, 1994 , and references therein). High calcium concentrations are necessary for stratification and desmosome assembly, although desmosomal proteins are synthesized in human keratinocytes grown in low-calcium media (Duden and Franke, 1988) . In mouse keratinocytes, calcium induces a G 1 cell-cycle arrest that results in part from increased p21WAFI and p27KIPI expression and subsequent inhibition of cyclin-dependent kinases (Missero et al., 1995 (Missero et al., , 1996 (Table 3) , and have been proposed to aid in the initial steps of CE assembly at or near the plasma membrane (Robinson et al., 1997) . The effects of calcium are mediated, at least in part, by the protein kinase C pathway, which induces late-differentiation markers (loricrin, profilaggrin) and CE formation (Dlugosz and Yuspa, 1993 , and references therein). Several PKC isoforms show changes in expression and activity during epithelial differentiation, including PKCcx, 8, E, (Denning et al., 1995 , and references therein). The PKC signal transduction pathway functions by activating APl family members (Rutberg et al., 1996) , leading to transcription of API-responsive genes such as KI, involucrin, loricrin, and profilaggrin (reviewed in Byrne, 1997; Eckert et al., 1997) . Other transcription factors that positively regulate the expression of epidermal differentiation markers include SP1, AP2, the homeodomain protein DOx3, and members of the ets family.
While the importance of calcium in regulating epithelial differentiation in vitro is unequivocal, its significance in vivo is unclear. The main "evidence" that calcium plays a role in vivo is the presence of a calcium gradient in epidermis that increases from the basal to the granular cell layer (Menon et al., 1985; Menon and Elias, 1991) . Calcium is also important for the secretion of lipid lamellar bodies from granular cells during terminal differentiation (Menon et al., 1994) and possibly for the formation of a competent epidermal barrier during fetal development (Elias et al., 1998b) . The calcium concentrations required for in vitro expression of late-differentiation markers (i.e., loricrin, profilaggrin) are higher than those required for Kl/KIO, supporting the notion that a calcium gradient might regulate epidermal differentiation in vivo (Yuspa et al., 1989) . In vitro studies also have shown that alteration of intracellular calcium pools can influence differentiation . The recent observation that mutations in an intracellular calcium pump causes Darier's disease, an epithelial disorder characterized by loss of adhesion (acantholysis) of suprabasal cells and aberrant keratinization, highlights the importance of calcium in normal desmosome assembly and function in the attachment of keratin filaments (Sakuntabhai et al., 1999) . The mutated gene (ATP2A2) encodes a sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) pump. It is interesting that, like the desmoplakin mutation reported recently (Keith et al., 1999 ), Darier's disease is autosomal-dominant and was suggested to result from haploinsufficiency (i.e., half the normal levels of protein) of these essential calcium channels in keratinocytes.
Another factor that influences epithelial differentiation is retinoic acid (RA), a metabolite of vitamin A (reviewed in Dale et al., 1990b; Fuchs, 1990 (Fisher et al., 1995; Fisher and Voorhees, 1996) . RAR/RXR functions are modulated by transcriptional co-activators or corepressors that influence retinoid signaling (Shibata et al., 1997) . RA has been shown to inhibit the in vitro differentiation of both epidermal and oral keratinocytes and expression of many markers, including KI, KIO, profilaggrin, and loricrin (Dale et al., 1990b; Fuchs, 1990; Fisher et ai., 1995) . In vivo, however, RA has the reverse effect on expression of many markers and results in hyperproliferation and thickening of epidermis (Fisher and Voorhees, 1996) . In some keratin genes, RA mediates alteration in gene transcription by direct binding of ligand-activated receptors to a negative RARE (RA response element) (Tomic-Canic et al., 1996; Radoja et al., 1997) or by alteration of API-mediated transcription (Lu et al., 1994) . In other epithelial genes, such as K6 (Navarro et al., 1995) and cellular retinoic acid binding protein II (Astrom et al., 1994) , RA (Kautsky et al., 1995; Schon and Rheinwald, 1996) . RA appears to induce K19 expression by a posttranscriptional mechanism involving increased mRNA stability (Crowe, 1993) .
Several other receptors that form heterodimers with RXR influence epithelial differentiation, including vitamin D receptor (VDR) (Bikle and Pillai, 1993) and peroxisomal proliferator-activated receptors (Hanley et al., 1998) . 1,25-Dihydroxyvitamin D3 (vitamin D) inhibits proliferation of epidermal keratinocytes through induction of TGF3 and the cyclin-dependent cell-cycle inhibitors p2IWAFI and p27KIPl, and also induces differentiation (Segaert et al., 1997) . Defining the role of retinoids and other receptors has been complicated by the cross-talk that occurs between these pathways. For example, vitamin D and retinoid receptors can transactivate gene expression as homodimers or as heterodimers with RXRs or other partners such as thyroid hormone receptor (Fisher et al., 1995; Fisher and Voorhees, 1996; Tomic-Canic et al., 1996) . Thus, transgenic mice expressing non-functional, dominant-negative forms of RARcx exhibit defects in normal skin development and maturation; however, it was unclear whether these effects were due to disruption of the retinoid signaling pathway or occurred because other pathways that require RXR have been interfered with (Imakado et al., 1995; Saitou et al., 1995) . However, transgenic mice expressing a dominant-negative version of RXRx showed no epidermal abormalities, supporting the view that RARs constitute the predominant pathway that regulates epidermal differentiation and development of a competent barrier (Feng et al., 1997 copy of a gene into patients, holds great promise (for reviews, see Garlick and Fenives, 1996; Verma and Somia, 1997) . Several studies have been reported in which epidermal keratinocytes from patients with recessive lamellar ichthyosis have been genetically modified and transplanted back into immune-deficient mice, with the expression of normal transglutaminase 1 enzyme and at least partial correction of the disease phenotype (reviewed in Khavari, 1998) . However, only very recently have vectors been developed that exhibit the necessary characteristics of long-term expression at a high level in vivo after only one injection of engineered virus (Kafri et al., 1997 , Wang et al., 1999 . Many of the keratinopathies are dominant diseases, providing even greater hurdles for treatment (Table 1) (Khavari, 1998) . In these disorders, it will be necessary for expression of the mutant allele to be selectively disrupted, while the normal allele is left functional.
Epithelial tissues regulate the balance between proliferation and differentiation by a variety of pathways, including calcium, protein kinase C, and retinoids. Many skin disorders that result from mutations in keratins or desmosomal components exhibit hyperproliferation and erythema (reddening of the skin). The mechanisms are thought to involve activation of growth factor/receptor and/or cytokine pathways but are poorly understood. In many cases, the best available treatments (retinoids or corticosteroids) are broad-spectrum in action and hence have undesirable side-effects. With our increased understanding of the biologic processes involved, better drugs that are more specific and have fewer sideeffects are being developed for many disorders, including those that affect the skin and oral mucosa (Girod and Pfahl, 1996; Duvic et al., 1998 (deRisi et al., 1996) . The future of both basic and applied epithelial biology is indeed bright.
